Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 1

Review

Bevacizumab in the therapy for refractory metastatic colorectal cancer

       
Total article views   HTML views PDF downloads Totals
6,952 Dovepress* 6,952+ 1,957 8,909
Totals 6,952 1,957 8,909
*Since 7 March 2008
+Since July 2016

View citations on Google Scholar